<Record><identifier xmlns="http://purl.org/dc/elements/1.1/">URN:NBN:SI:doc-6SZKW6XJ</identifier><date>2010</date><creator>Krapež, Milka</creator><relation>documents/doc/6/URN_NBN_SI_doc-6SZKW6XJ_001.htm</relation><relation>documents/doc/6/URN_NBN_SI_doc-6SZKW6XJ_001.pdf</relation><relation>documents/doc/6/URN_NBN_SI_doc-6SZKW6XJ_001.txt</relation><format format_type="issue">2</format><format format_type="volume">61</format><format format_type="type">article</format><format format_type="extent">str. 130-131</format><identifier identifier_type="ISSN">0014-8229</identifier><identifier identifier_type="COBISSID">24150311</identifier><identifier identifier_type="URN">URN:NBN:SI:doc-6SZKW6XJ</identifier><language>slv</language><publisher>Slovensko farmacevtsko društvo</publisher><source>Farmacevtski vestnik</source><rights>InC</rights><subject language_type_id="slv">generična zdravila</subject><subject language_type_id="slv">pravice bolnikov</subject><title>izkušnje bolnikov</title><title>Vpliv uvedbe sistema zamenljivih zdravil na bolnike</title></Record>